Bexagliflozin Tablet
Product Images NDC 51407-918

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bexagliflozin (NDC 51407-918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-918-30ol (Bexagliflozin Tablets)

51407-918-30ol (Bexagliflozin Tablets)
This is a description of Gliflozin tablets with bexagliflozin 20 mg. It is advised to dispense the Medication Guide to each patient and not to accept if bottle seal is broken. The tablets should not be crushed or chewed, and should be kept out of the reach of children. The tablets should be stored at 20° - 25°C (68° - 77°F). Further dosage information can be found in the accompanying Prescribing Information. This medication is marketed by GSMS, Incorporated located in Camarillo, CA.*
FDA Label Image

Bexagliflozin Pi- Chart_page_1.jpg (Bexagliflozin Pi Chart Page 1)

Bexagliflozin Pi- Chart_page_1.jpg (Bexagliflozin Pi  Chart Page 1)
This text provides data on the change in values of Bexagliflozin compared to a Placebo over a 24-week period. The numbers listed indicate measurements taken at different time points. Bexagliflozin values start at 138 and gradually decrease, while Placebo values fluctuate between 69 and 85 and then stabilize around 64.*
FDA Label Image

Bexagliflozin-figure-1 (Bexagliflozin Figure 1)

FDA Label Image

Bexagliflozin-figure-2 (Bexagliflozin Figure 2)

Bexagliflozin-figure-2 (Bexagliflozin Figure 2)
This information seems to be a list of pharmacokinetic parameters for different medications including Metformin, Glimepiride, Sitagliptin, and Digoxin. It provides data on the area under the curve (AUC) and the maximum concentration (Cmax) for each medication. The text also mentions the geometric mean ratio with a 90% confidence interval. This data is important for understanding how the medications are metabolized and their potential interactions.*
FDA Label Image

Bexagliflozin-structure (Bexagliflozin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.